It was shown that IGF2BP1 can enhance c-Myc and Ki-67 protein translation and promote HCC progression by binding and stabilizing proliferation markers C-Myc and Ki-67 (MKI67) (Gutschner et al., 2014). This evidence concerns the gene IGF2BP1 and hepatocellular carcinoma.